Your Dedicated Platform for T-Cell Engagers for Autoimmune Diseases to Foster New & Existing Relationships with Key Decision Makers Seeking Your Expertise
The 2nd T-Cell Engager for Autoimmune Disease Summit is designed to address the most critical challenges in developing safer, more effective, and clinically differentiated T-cell engagers for autoimmune disease.
Developed in close collaboration with autoimmune T-cell engager pioneers across discovery, translational, and clinical development, the summit focuses on advancing progress across key areas, including:
- Engineering next-generation T-cell engagers through CD3 tuning, conditional activation, trispecific designs, and immune synapse optimization to improve safety and reduce CRS
- Predictive translational strategies using humanized models, patient-derived assays, biomarkers, and early clinical data to accelerate development
- Precision target discovery beyond conventional B-cell depletion, including peptide-HLA targets, plasma cells, and autoreactive immune-cell populations
- Strategies to overcome key biological barriers including tissue penetration, T-cell exhaustion, and durable immune-cell depletion
- Clinical development, dose optimization, and safety management approaches to improve tolerability and maximize long-term efficacy
- Regulatory, competitive, and commercial strategies to differentiate autoimmune T-cell engager programs and accelerate clinical success
Partner with us in 2026 to position your organization as a leader in autoimmune T-cell engager innovation and gain direct access to a highly targeted audience of senior discovery, translational, clinical, and business development leaders actively seeking new technologies, platforms, services, and strategic partnerships.
Powering Innovation in T-Cell Engager for Autoimmune Disease Research
Attendees from leading biopharma and biotech companies are actively seeking partners with expertise in T-cell engager engineering, translational science, biomarker development, immune profiling, and clinical development. Partnering with the 2nd T-Cell Engager for Autoimmune Disease Summit connects you directly with the decision-makers developing the next generation of autoimmune T-cell engager therapies.
This is where solution providers meet the leaders shaping safer, more effective autoimmune T-cell engager pipelines from discovery through clinical development.
Integrated CROs & CDMOs
Autoimmune T-cell engager developers require integrated partners to accelerate programs from discovery through clinical development. Showcase your expertise in antibody engineering, cell line development, analytical characterization, GMP manufacturing, and CMC support to help developers streamline development, reduce risk, and bring next-generation T-cell engagers to the clinic faster.
Specialised Antibody Discovery Platforms
As developers seek safer and more selective autoimmune T-cell engagers, innovative antibody discovery technologies are critical for identifying differentiated binders and novel formats. Demonstrate how your platform enables rapid discovery, optimization, and engineering of bispecific, trispecific, and next-generation immune engager molecules.
Antibody & Protein Providers
Developers rely on high-quality recombinant proteins, antibodies, antigens, and assay reagents to support target validation, screening, and translational research. Position your portfolio as an essential resource for accelerating autoimmune T-cell engager discovery and preclinical development.
Advanced Formatting Specialists
Next-generation autoimmune T-cell engagers require increasingly sophisticated molecular architectures to balance efficacy with safety. Highlight your expertise in advanced protein engineering, multispecific formats, half-life extension, Fc engineering, and developability optimization to help developers create differentiated therapeutic candidates.
Autoimmune Models
Predictive preclinical models are essential for evaluating efficacy, cytokine release, and immune-cell depletion before entering the clinic. Demonstrate how your humanized models, patient-derived systems, organoids, and autoimmune disease platforms improve translational confidence and accelerate successful clinical development.
Hear What Our Past Sponsors Have to Say
Smaller group, poster session with opportunity to network
COO, Structura Biotechnology
The caliber of the attendees was very high, and the meeting content was excellent
Project Leader, Evotec
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive dinners and tours to help elevate your brand.
Attending Companies Include
Maintain Your Competitive Edge
Position yourself alongside other solution providers to ensure your brand is at the heart of biopharma discussions
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.